Peripheral channelopathies as targets for potassium channel openers

Citation
K. Lawson et Mj. Dunne, Peripheral channelopathies as targets for potassium channel openers, EXPERT OP I, 10(7), 2001, pp. 1345-1359
Citations number
126
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EXPERT OPINION ON INVESTIGATIONAL DRUGS
ISSN journal
13543784 → ACNP
Volume
10
Issue
7
Year of publication
2001
Pages
1345 - 1359
Database
ISI
SICI code
1354-3784(200107)10:7<1345:PCATFP>2.0.ZU;2-K
Abstract
Potassium channel openers (KCOs) are important tools that are often used to gain a greater understanding of K+ channels. Agents that can induce or mai ntain the opening of K+ channels also offer a therapeutic approach to contr olling of cell excitability and offer a means of producing stability in bio logical systems. The pathogenesis of a broad range of peripheral disorders (e.g., LQT syndrome, hypokalemic periodic paralysis, hyperinsulinism in inf ancy and erectile dysfunction) are associated with dysfunctional K+ channel s due to mutations in genes encoding channel proteins. The therapeutic pote ntial of KCOs in peripheral K+ channelopathies is discussed. The identifica tion of K+ channel subtype-specific openers offers discrete modulation of c ellular systems creating a realistic therapeutic advance in the treatment o f K+ channelopathies.